Active, not recruitingPhase 3NCT05095376
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Studying Gliosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NRG Oncology
- Principal Investigator
- Fabio M Iwamoto, M.DNRG Oncology
- Intervention
- Lomustine(drug)
- Enrollment
- 265 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2022 – 2026
Study locations (30)
- Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
- Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Highlands Oncology Group - Rogers, Rogers, Arkansas, United States
- Highlands Oncology Group, Springdale, Arkansas, United States
- Kaiser Permanente-Anaheim, Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States
- Sutter Auburn Faith Hospital, Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
- Kaiser Permanente-Bellflower, Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
- Mercy Cancer Center - Carmichael, Carmichael, California, United States
- Mercy San Juan Medical Center, Carmichael, California, United States
- John Muir Medical Center-Concord, Concord, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05095376 on ClinicalTrials.govOther trials for Gliosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07134842A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.University College, London
- ENROLLING BY INVITATIONPHASE1NCT06896110Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaAndrew P. Groves
- RECRUITINGPHASE1NCT06934889Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaMemorial Sloan Kettering Cancer Center
- RECRUITINGNCT05756985Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain TissueBaptist Health South Florida
- RECRUITINGPHASE2NCT05864534Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern University
- RECRUITINGNCT06954636Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational StudySied Kebir
- RECRUITINGPHASE1NCT04991870Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT05363826Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®Photolitec LLC